In addition, they and a more recent report from Fu and colleagues both showed that tumor-infiltrating CD4+ and CD8+ T cells expressed a significantly greater percentage of TIM-3 positivity compared to peripheral CD4+ and CD8+ T cells in matched glioma and glioblastoma samples respectively [71,98]. The gene discussed is CD4; the disease is glioblastoma.